The New York Times report highlights ongoing insurer delays in prior authorization despite reform promises, yet it underplays the systemic entrenchment documented in peer-reviewed literature. An observational survey by the American Medical Association (n=1,000+ physicians, 2023) found 94% reporting care delays from prior auth, with no RCT-level controls but consistent patterns across specialties; conflicts of interest were minimal as it was physician-led. This connects to a 2021 Health Affairs analysis of claims data (observational, millions of encounters) showing prior auth disproportionately burdens chronic disease management, inflating costs by 10-15% without improving outcomes. The coverage misses how these hurdles amplify affordability failures, linking to broader patterns where administrative burdens contribute to 30% of U.S. healthcare spending per OECD comparisons. Patients face denied or postponed treatments, directly worsening access inequities beyond what anecdotal complaints reveal.